1. Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology. (June 2019) Authors: Salgado, Roberto; Solit, David B.; Rimm, David L.; Bogaerts, Jan; Canetta, Renzo; Lively, Tracy; Lyerly, Kim; Span, Paul N.; Bateman-House, Alison; Makady, Amr; Bergmann, L.; Nagai, Sumimasa; Smith, Chris; Robson, Mark; Savage, Mary; Voest, Emile; Sweeney, Christopher; Lambin, Philippe; Thomas, M... Journal: European journal of cancer Issue: Volume 114(2019) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O1–11–02: Kinetics of CNS APP metabolites in the presence of a BACE1 inhibitor in a non‐human primate model. (1st July 2013) Authors: Dobrowolska, Justyna; Michener, Maria; Wu, Guoxin; Patterson, Bruce; Chott, Robert; Ovod, Vitaliy; Pyatkivskyy, Yuriy; Wildsmith, Kristin; Kasten, Tom; Mathers, Parker; Dancho, Mandy; Lennox, Christina; Smith, Brad; Gilberto, David; McLoughlin, Debra; Holder, Dan; Stamford, Andrew; Yarasheski, Ke... Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 4 Page Start: P151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1–140: Soluble BACE activity and sAPPβ levels do not differentiate Alzheimer's disease and age‐matched control cerebrospinal fluid in the ADNI‐1 cohort. (1st July 2013) Authors: Savage, Mary; Holder, Dan; Wu, Guoxin; Kaplow, June M.; Siuciak, Judith; Potter, William Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 5 Page Start: P201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1–361: Improved interpretation of amyloid tracer kinetic data through model‐based analysis. (1st July 2013) Authors: Stone, Julie; Kleijn, Huub Jan; Bradstreet, Thomas E.; Drexel, Melissa; Savage, Mary; Forman, Mark; Spellman, Daniel; Laterza, Omar; Chappell, Derek; Chappell, Gloria; Tanen, Michael; Cumming, Jared; Hyde, Lynn; Kennedy, Matthew; Struyk, Arie Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P3‐073: Intervention of TAU Pathology Prevents Behavioral Changes in RTG4510 Mouse Model of Tauopathy. (1st July 2016) Authors: Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali; Marcus, Jacob; Hess, Fred; Savage, Mary; Renger, John J.; Rosahl, Thomas W.; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 17 Page Start: P845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4‐036: Pharmacokinetics and Pharmacodynamics to Support Clinical Studies of MK‐8719: an O‐Glcnacase Inhibitor for Progressive Supranuclear Palsy. (1st July 2016) Authors: Sandhu, Punam; Lee, Junghoon; Ballard, Jeanine; Walker, Brittany; Ellis, Joan; Marcus, Jacob; Toolan, Dawn; Dreyer, Daniel; McAvoy, Thomas; Duffy, Joseph; Michener, Maria; Valiathan, Chandni; Trainor, Nicole; Savage, Mary; McEachern, Ernest; Vocadlo, David; Smith, Sean M.; Struyk, Arie Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 21 Page Start: P1028 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Issue 10318 (18th December 2021) Authors: Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; va... Journal: Lancet Issue: Volume 398:Issue 10318(2021) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Issue 8 (August 2022) Authors: Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Al... Journal: Lancet infectious diseases Issue: Volume 22:Issue 8(2022) Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review. Issue 10 (22nd June 2018) Authors: Hansson, Oskar; Mikulskis, Alvydas; Fagan, Anne M.; Teunissen, Charlotte; Zetterberg, Henrik; Vanderstichele, Hugo; Molinuevo, Jose Luis; Shaw, Leslie M.; Vandijck, Manu; Verbeek, Marcel M.; Savage, Mary; Mattsson, Niklas; Lewczuk, Piotr; Batrla, Richard; Rutz, Sandra; Dean, Robert A.; Blennow, Kaj Journal: Alzheimer's & dementia Issue: Volume 14:Issue 10(2018) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗